Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging
Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including autism, intellectual disability and schizophrenia. To gain insight into NRXN1’s involvement in human cortical development we used quantitati...
Saved in:
| Published in | Molecular psychiatry Vol. 21; no. 5; pp. 701 - 706 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
01.05.2016
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including autism, intellectual disability and schizophrenia. To gain insight into NRXN1’s involvement in human cortical development we used quantitative real-time PCR to examine the expression trajectories of NRXN1, and its predominant isoforms, NRXN1-α and NRXN1-β, in prefrontal cortex from fetal stages to aging. In addition, we investigated whether prefrontal cortical expression levels of NRXN1 transcripts are altered in schizophrenia or bipolar disorder in comparison with non-psychiatric control subjects. We observed that all three NRXN1 transcripts were highly expressed during human fetal cortical development, markedly increasing with gestational age. In the postnatal dorsolateral prefrontal cortex, expression levels were negatively correlated with age, peaking at birth until ~3 years of age, after which levels declined markedly to be stable across the lifespan. NRXN1-β expression was modestly but significantly elevated in the brains of patients with schizophrenia compared with non-psychiatric controls, whereas NRXN1-α expression was increased in bipolar disorder. These data provide novel evidence that NRXN1 expression is highest in human dorsolateral prefrontal cortex during critical developmental windows relevant to the onset and diagnosis of a range of neurodevelopmental disorders, and that NRXN1 expression may be differentially altered in neuropsychiatric disorders. |
|---|---|
| AbstractList | Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including autism, intellectual disability and schizophrenia. To gain insight into NRXN1's involvement in human cortical development we used quantitative real-time PCR to examine the expression trajectories of NRXN1, and its predominant isoforms, NRXN1-α and NRXN1-β, in prefrontal cortex from fetal stages to aging. In addition, we investigated whether prefrontal cortical expression levels of NRXN1 transcripts are altered in schizophrenia or bipolar disorder in comparison with non-psychiatric control subjects. We observed that all three NRXN1 transcripts were highly expressed during human fetal cortical development, markedly increasing with gestational age. In the postnatal dorsolateral prefrontal cortex, expression levels were negatively correlated with age, peaking at birth until ~3 years of age, after which levels declined markedly to be stable across the lifespan. NRXN1-β expression was modestly but significantly elevated in the brains of patients with schizophrenia compared with non-psychiatric controls, whereas NRXN1-α expression was increased in bipolar disorder. These data provide novel evidence that NRXN1 expression is highest in human dorsolateral prefrontal cortex during critical developmental windows relevant to the onset and diagnosis of a range of neurodevelopmental disorders, and that NRXN1 expression may be differentially altered in neuropsychiatric disorders. Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including autism, intellectual disability and schizophrenia. To gain insight into NRXN1's involvement in human cortical development we used quantitative real-time PCR to examine the expression trajectories of NRXN1, and its predominant isoforms, NRXN1-α and NRXN1-β, in prefrontal cortex from fetal stages to aging. In addition, we investigated hether prefrontal cortical expression levels of NRXN1 transcripts are altered in schizophrenia or bipolar disorder in comparison with non-psychiatric control subjects. We observed that all three NRXN1 transcripts were highly expressed during human fetal cortical development, markedly increasing with gestational age. In the postnatal dorsolateral prefrontal cortex, expression levels were negatively correlated with age, peaking at birth until ~3 years of age, after which levels declined markedly to be stable across the lifespan. NRXN1-β expression was modestly but significantly elevated in the brains of patients with schizophrenia compared with non- psychiatric controls, whereas NRXN1-α expression was increased in bipolar disorder. These data provide novel evidence that NRXN1 expression is highest in human dorsolateral prefrontal cortex during critical developmental windows relevant to the onset and diagnosis of a range of neurodevelopmental disorders, and that NRXN1 expression may be differentially altered in neuropsychiatric disorders. Molecular Psychiatry (2016) 21, 701-706; doi: 10.1038/mp.2015.107; published online 28 July 2015 Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including autism, intellectual disability and schizophrenia. To gain insight into NRXN1's involvement in human cortical development we used quantitative real-time PCR to examine the expression trajectories of NRXN1, and its predominant isoforms, NRXN1-α and NRXN1-β, in prefrontal cortex from fetal stages to aging. In addition, we investigated whether prefrontal cortical expression levels of NRXN1 transcripts are altered in schizophrenia or bipolar disorder in comparison with non-psychiatric control subjects. We observed that all three NRXN1 transcripts were highly expressed during human fetal cortical development, markedly increasing with gestational age. In the postnatal dorsolateral prefrontal cortex, expression levels were negatively correlated with age, peaking at birth until ~3 years of age, after which levels declined markedly to be stable across the lifespan. NRXN1-β expression was modestly but significantly elevated in the brains of patients with schizophrenia compared with non-psychiatric controls, whereas NRXN1-α expression was increased in bipolar disorder. These data provide novel evidence that NRXN1 expression is highest in human dorsolateral prefrontal cortex during critical developmental windows relevant to the onset and diagnosis of a range of neurodevelopmental disorders, and that NRXN1 expression may be differentially altered in neuropsychiatric disorders.Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including autism, intellectual disability and schizophrenia. To gain insight into NRXN1's involvement in human cortical development we used quantitative real-time PCR to examine the expression trajectories of NRXN1, and its predominant isoforms, NRXN1-α and NRXN1-β, in prefrontal cortex from fetal stages to aging. In addition, we investigated whether prefrontal cortical expression levels of NRXN1 transcripts are altered in schizophrenia or bipolar disorder in comparison with non-psychiatric control subjects. We observed that all three NRXN1 transcripts were highly expressed during human fetal cortical development, markedly increasing with gestational age. In the postnatal dorsolateral prefrontal cortex, expression levels were negatively correlated with age, peaking at birth until ~3 years of age, after which levels declined markedly to be stable across the lifespan. NRXN1-β expression was modestly but significantly elevated in the brains of patients with schizophrenia compared with non-psychiatric controls, whereas NRXN1-α expression was increased in bipolar disorder. These data provide novel evidence that NRXN1 expression is highest in human dorsolateral prefrontal cortex during critical developmental windows relevant to the onset and diagnosis of a range of neurodevelopmental disorders, and that NRXN1 expression may be differentially altered in neuropsychiatric disorders. Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including autism, intellectual disability and schizophrenia. To gain insight into NRXN1's involvement in human cortical development we used quantitative real-time PCR to examine the expression trajectories of NRXN1, and its predominant isoforms, NRXN1-α and NRXN1-β, in prefrontal cortex from fetal stages to aging. In addition, we investigated hether prefrontal cortical expression levels of NRXN1 transcripts are altered in schizophrenia or bipolar disorder in comparison with non-psychiatric control subjects. We observed that all three NRXN1 transcripts were highly expressed during human fetal cortical development, markedly increasing with gestational age. In the postnatal dorsolateral prefrontal cortex, expression levels were negatively correlated with age, peaking at birth until ~3 years of age, after which levels declined markedly to be stable across the lifespan. NRXN1-β expression was modestly but significantly elevated in the brains of patients with schizophrenia compared with non- psychiatric controls, whereas NRXN1-α expression was increased in bipolar disorder. These data provide novel evidence that NRXN1 expression is highest in human dorsolateral prefrontal cortex during critical developmental windows relevant to the onset and diagnosis of a range of neurodevelopmental disorders, and that NRXN1 expression may be differentially altered in neuropsychiatric disorders. Neurexin 1 (NRXN1), a presynaptic adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including, autism, intellectual disability, and schizophrenia. To gain insight into NRXN1’s involvement in human cortical development we used quantitative real time PCR to examine the expression trajectories of NRXN1, and its predominant isoforms NRXN1-α and NRXN1-β in prefrontal cortex from fetal stages to aging. Additionally, we investigated whether prefrontal cortical expression levels of NRXN1 transcripts are altered in schizophrenia or bipolar disorder in comparison to non-psychiatric control subjects. We observed that all three NRXN1 transcripts were highly expressed during human fetal cortical development, dramatically increasing with gestational age. In the postnatal DLPFC, expression levels were negatively correlated with age, peaking at birth until approximately 3 years of age, after which levels declined dramatically to be stable across the lifespan. NRXN1-β expression was modestly but significantly elevated in the brains of patients with schizophrenia compared to non-psychiatric controls, whereas NRXN1-α expression was increased in bipolar disorder. These data provide novel evidence that NRXN1 expression is highest in human prefrontal cortex during critical developmental windows relevant to the onset and diagnosis of a range of neurodevelopmental disorders, and that NRXN1 expression may be differentially altered in neuropsychiatric disorders. Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including autism, intellectual disability and schizophrenia. To gain insight into NRXN1's involvement in human cortical development we used quantitative real-time PCR to examine the expression trajectories of NRXN1, and its predominant isoforms, NRXN1- alpha and NRXN1- beta , in prefrontal cortex from fetal stages to aging. In addition, we investigated whether prefrontal cortical expression levels of NRXN1 transcripts are altered in schizophrenia or bipolar disorder in comparison with non-psychiatric control subjects. We observed that all three NRXN1 transcripts were highly expressed during human fetal cortical development, markedly increasing with gestational age. In the postnatal dorsolateral prefrontal cortex, expression levels were negatively correlated with age, peaking at birth until ~3 years of age, after which levels declined markedly to be stable across the lifespan. NRXN1- beta expression was modestly but significantly elevated in the brains of patients with schizophrenia compared with non-psychiatric controls, whereas NRXN1- alpha expression was increased in bipolar disorder. These data provide novel evidence that NRXN1 expression is highest in human dorsolateral prefrontal cortex during critical developmental windows relevant to the onset and diagnosis of a range of neurodevelopmental disorders, and that NRXN1 expression may be differentially altered in neuropsychiatric disorders. |
| Audience | Academic |
| Author | Kleinman, J E Paterson, C Hyde, T M Wang, Y Jenkins, A K Law, A J |
| AuthorAffiliation | 3 Department of Psychiatry, University of Colorado, School of Medicine, Aurora, CO 80045, USA 1 Clinical Brain Disorder Branch, Intramural Research Program, National Institutes of Health, Bethesda, MD 20892 USA 4 Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA 2 University of Kentucky, College of Medicine, Lexington, KY, USA |
| AuthorAffiliation_xml | – name: 3 Department of Psychiatry, University of Colorado, School of Medicine, Aurora, CO 80045, USA – name: 1 Clinical Brain Disorder Branch, Intramural Research Program, National Institutes of Health, Bethesda, MD 20892 USA – name: 2 University of Kentucky, College of Medicine, Lexington, KY, USA – name: 4 Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD, USA |
| Author_xml | – sequence: 1 givenname: A K surname: Jenkins fullname: Jenkins, A K organization: Clinical Brain Disorder Branch, Intramural Research Program, National Institutes of Health, University of Kentucky, College of Medicine – sequence: 2 givenname: C surname: Paterson fullname: Paterson, C organization: Clinical Brain Disorder Branch, Intramural Research Program, National Institutes of Health, Department of Psychiatry and Cell and Developmental Biology, University of Colorado, School of Medicine – sequence: 3 givenname: Y surname: Wang fullname: Wang, Y organization: Clinical Brain Disorder Branch, Intramural Research Program, National Institutes of Health, Lieber Institute for Brain Development, Johns Hopkins University Medical Campus – sequence: 4 givenname: T M surname: Hyde fullname: Hyde, T M organization: Lieber Institute for Brain Development, Johns Hopkins University Medical Campus – sequence: 5 givenname: J E surname: Kleinman fullname: Kleinman, J E organization: Lieber Institute for Brain Development, Johns Hopkins University Medical Campus – sequence: 6 givenname: A J surname: Law fullname: Law, A J email: amanda.law@ucdenver.edu organization: Clinical Brain Disorder Branch, Intramural Research Program, National Institutes of Health, Department of Psychiatry and Cell and Developmental Biology, University of Colorado, School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26216298$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkk1r3DAQhkVJaZJtT70XQS8prbeSJVnypRBCvyBsoeRQ6EFo5fFGwZYcyQ7pv6-cTdokbKHMQR_zzCvN8B6iPR88IPSSkiUlTL3vh2VJqMgH-QQdUC6rQgip9vKeibrgVPF9dJjSBSFzUjxD-2VV0qqs1QH6uYIpwrXzmOKj1fcfK_oGp6FzFrBLoQ2xx3A9REjJBY-bKTq_wedTbzz2EGyIo7Omww1cQReGHvyIjW-w2WTuOXrami7Bi9t1gc4-fTw7-VKcfvv89eT4tLAVJ2NhgQlBbGXaxlS2LYkphSIUlISWr5U1AsjalFxwAaZlhEiwTDDCSV2va2AL9GErO0zrHhqb_xBNp4foehN_6WCcfpjx7lxvwpXmklFGqyxwdCsQw-UEadS9Sxa6zuQWp6SpVLKulJDkf9BSMcKy8AK9foRehCn6PAhdVlxISdSN4D-prEVvQv2lNqYD7XwbciN2flofc1GqPC4yv7jcQeVooHc2m6Z1-f5Bwav7k_szsjt7ZIBuARtDShFabd1oxmyFrOw6TYmeLaj7Qc8WzAeZa94-qrmT3U2_29JpmK0F8V7_O_Df8aHoLA |
| CitedBy_id | crossref_primary_10_1002_jat_4206 crossref_primary_10_1038_s41380_019_0438_9 crossref_primary_10_1093_cercor_bhae291 crossref_primary_10_1002_ajmg_b_32664 crossref_primary_10_1016_j_neubiorev_2020_02_005 crossref_primary_10_1038_s41380_021_01037_w crossref_primary_10_3390_jfmk6020048 crossref_primary_10_1093_nargab_lqae006 crossref_primary_10_3390_genes14112051 crossref_primary_10_1080_15622975_2016_1268715 crossref_primary_10_1038_nrn_2017_125 crossref_primary_10_1007_s12035_017_0834_6 crossref_primary_10_1016_j_gde_2021_02_010 crossref_primary_10_1159_000524710 crossref_primary_10_1016_j_celrep_2019_05_090 crossref_primary_10_1038_s41588_019_0539_z crossref_primary_10_1016_j_jbc_2023_105168 crossref_primary_10_3233_JAD_160949 crossref_primary_10_1016_j_neuron_2021_10_035 crossref_primary_10_3390_jpm11070637 crossref_primary_10_4103_1673_5374_249283 crossref_primary_10_1038_s41467_023_39420_6 crossref_primary_10_1038_srep25671 crossref_primary_10_1016_j_biopsych_2021_10_018 crossref_primary_10_1093_cercor_bhw394 crossref_primary_10_1038_s41467_017_00831_x crossref_primary_10_1159_000495063 crossref_primary_10_1016_j_genrep_2023_101774 crossref_primary_10_3390_jcm13072067 crossref_primary_10_1016_j_ajp_2024_104071 crossref_primary_10_3389_fpsyg_2019_00521 crossref_primary_10_1016_j_psychres_2018_04_036 crossref_primary_10_21931_RB_2019_04_02_12 crossref_primary_10_31083_j_jin2310184 crossref_primary_10_1007_s12035_021_02561_0 crossref_primary_10_1016_j_jad_2024_06_032 crossref_primary_10_1093_cercor_bhw407 crossref_primary_10_1176_appi_ajp_2016_16060721 crossref_primary_10_1016_j_neubiorev_2018_02_010 crossref_primary_10_1007_s13402_021_00619_8 crossref_primary_10_1002_syn_22276 crossref_primary_10_1038_s41525_024_00450_8 crossref_primary_10_1177_09727531251322019 crossref_primary_10_3390_genes13010028 crossref_primary_10_1016_j_yexcr_2019_06_014 |
| Cites_doi | 10.1523/JNEUROSCI.15-04-02849.1995 10.1016/j.schres.2014.02.023 10.1093/hmg/ddr208 10.1016/j.ajhg.2007.12.009 10.1016/S0168-9525(97)01324-3 10.1016/j.cell.2004.11.035 10.1038/npp.2014.65 10.1002/ajmg.b.32148 10.1073/pnas.96.3.1100 10.1038/nature08185 10.1002/ajmg.b.31063 10.1093/hmg/ddn351 10.1126/science.1155174 10.1038/ng1985 10.1038/nature07239 10.1093/hmg/ddn044 10.1016/j.neuron.2006.06.005 10.1186/1471-2350-12-106 10.1016/S0149-7634(03)00005-8 10.1002/ajmg.b.32232 10.1038/nature07456 10.1016/j.ajhg.2008.09.011 10.1093/hmg/ddm323 10.1038/ejhg.2008.264 10.1523/JNEUROSCI.0470-10.2010 10.1002/hup.1146 10.1038/tpj.2013.51 10.1371/journal.pone.0018579 10.1074/jbc.M703957200 10.1006/geno.2002.6734 10.1016/j.biopsych.2009.08.034 10.1016/j.cell.2011.11.028 10.1016/j.neulet.2005.10.076 10.1006/geno.2002.6780 10.1523/JNEUROSCI.1253-05.2006 10.1038/npp.2009.115 10.1038/ng1136 10.1038/nature07953 10.1038/ejhg.2013.248 10.1016/j.neuron.2010.04.008 10.1016/j.schres.2011.08.007 10.1371/journal.pone.0110482 10.1016/j.neuron.2005.08.026 10.1038/mp.2010.134 10.1078/0171-9335-00410 10.1073/pnas.1005410107 10.1016/j.bbrc.2006.11.008 10.1073/pnas.0602002103 10.1016/0006-8993(79)90349-4 10.1038/mp.2014.156 |
| ContentType | Journal Article |
| Copyright | Macmillan Publishers Limited 2016 COPYRIGHT 2016 Nature Publishing Group Copyright Nature Publishing Group May 2016 Macmillan Publishers Limited 2016. |
| Copyright_xml | – notice: Macmillan Publishers Limited 2016 – notice: COPYRIGHT 2016 Nature Publishing Group – notice: Copyright Nature Publishing Group May 2016 – notice: Macmillan Publishers Limited 2016. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
| DOI | 10.1038/mp.2015.107 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (via ProQuest) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest One Psychology ProQuest One Psychology MEDLINE - Academic Neurosciences Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1476-5578 |
| EndPage | 706 |
| ExternalDocumentID | PMC4731316 4027157781 A452880101 26216298 10_1038_mp_2015_107 |
| Genre | Journal Article Comparative Study Research Support, N.I.H., Intramural |
| GeographicLocations | United States--US Baltimore Maryland |
| GeographicLocations_xml | – name: United States--US – name: Baltimore Maryland |
| GrantInformation_xml | – fundername: Intramural NIH HHS grantid: Z99 MH999999 – fundername: NIMH NIH HHS grantid: R01 MH103716 |
| GroupedDBID | --- -Q- 0R~ 123 29M 2WC 36B 39C 3V. 4.4 406 53G 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYZH AAZLF ABAKF ABAWZ ABDBF ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACUHS ACZOJ ADBBV ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AXYYD AZQEC B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL EPS ESX F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR IPY ITC IWAJR JSO JZLTJ KQ8 M1P M2M M7P NAO NQJWS O9- OK1 OVD P2P PQQKQ PROAC PSQYO PSYQQ Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UKHRP ~8M AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB AEIIB PMFND 7TK 7XB 8FE 8FH 8FK K9. LK8 PKEHL PQEST PQUKI PRINS Q9U PUEGO 7X8 5PM |
| ID | FETCH-LOGICAL-c640t-ce3550c6afda6cf20a25801e87ef4b8ca5e0ba24545eaf3007ec35304099b9e3 |
| IEDL.DBID | 7X7 |
| ISSN | 1359-4184 1476-5578 |
| IngestDate | Thu Aug 21 18:07:49 EDT 2025 Thu Jul 10 20:00:47 EDT 2025 Fri Jul 11 01:33:49 EDT 2025 Sat Aug 23 14:30:49 EDT 2025 Fri Jul 25 09:15:23 EDT 2025 Tue Jun 17 21:46:21 EDT 2025 Tue Jun 10 20:38:34 EDT 2025 Mon Jul 21 05:58:46 EDT 2025 Tue Jul 01 00:21:45 EDT 2025 Thu Apr 24 22:58:28 EDT 2025 Fri Feb 21 02:39:32 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c640t-ce3550c6afda6cf20a25801e87ef4b8ca5e0ba24545eaf3007ec35304099b9e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC4731316 |
| PMID | 26216298 |
| PQID | 1781818188 |
| PQPubID | 44096 |
| PageCount | 6 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4731316 proquest_miscellaneous_1787968570 proquest_miscellaneous_1782830331 proquest_journals_2645770870 proquest_journals_1781818188 gale_infotracmisc_A452880101 gale_infotracacademiconefile_A452880101 pubmed_primary_26216298 crossref_citationtrail_10_1038_mp_2015_107 crossref_primary_10_1038_mp_2015_107 springer_journals_10_1038_mp_2015_107 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-05-01 |
| PublicationDateYYYYMMDD | 2016-05-01 |
| PublicationDate_xml | – month: 05 year: 2016 text: 2016-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England – name: New York |
| PublicationTitle | Molecular psychiatry |
| PublicationTitleAbbrev | Mol Psychiatry |
| PublicationTitleAlternate | Mol Psychiatry |
| PublicationYear | 2016 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Varoqueaux, Jamain, Brose (CR28) 2004; 83 Vrijenhoek, Buizer-Voskamp, van der Stelt, Strengman (CR13) 2008; 83 Gregor, Albrecht, Bader, Bijlsma, Ekici, Engels (CR6) 2011; 12 Iijima, Wu, Witte, Hanno-Iijima, Glatter, Richard (CR42) 2011; 147 Tansey, Rucker, Kavanagh, Guipponi, Perroud, Bondolfi (CR19) 2014; 14 Boucard, Chubykin, Comoletti, Taylor, Sudhof (CR29) 2005; 48 Need, Keefe, Ge, Grossman, Dickson, McEvoy (CR11) 2009; 17 Kirov, Gumus, Chen, Norton, Georgieva, Sari (CR8) 2008; 17 Ching, Shen, Tan, Jeste, Morrow, Chen (CR5) 2010; 153B Rozic, Lupowitz, Piontkewitz, Zisapel (CR43) 2011; 6 Souza, Meltzer, Lieberman, Le Foll, Kennedy (CR16) 2010; 25 Todarello, Feng, Kolachana, Li, Vakkalanka, Bertolino (CR15) 2014; 155 Lett, Tiwari, Meltzer, Lieberman, Potkin, Voineskos (CR17) 2011; 132 Tau, Peterson (CR36) 2010; 35 Kang, Zhang, Dobie, Wu, Craig (CR44) 2008; 283 Noor, Lionel, Cohen-Woods, Moghimi, Rucker, Fennell (CR49) 2014; 165B Brown, Clapcote, Millar, Torrance, Anderson, Walker (CR40) 2011; 16 Siddiqui, Pancaroglu, Kang, Rooyakkers, Craig (CR47) 2010; 30 Tabuchi, Sudhof (CR24) 2002; 79 Rowen, Young, Birditt, Kaur, Madan, Philipps (CR22) 2002; 79 Andersen (CR35) 2003; 27 Kao, Wang, Kleinman, Lipska, Hyde, Weinberger (CR34) 2010; 107 Paraoanu, Becker-Roeck, Christ, Layer (CR39) 2006; 395 Chih, Gollan, Scheiffele (CR45) 2006; 51 Huttenlocher (CR37) 1979; 163 Sudhof (CR25) 2008; 455 Sun, Cheng, Qin, Liao, Chen, Koong (CR31) 2011; 20 Bena, Bruno, Eriksson, van Ravenswaaij-Arts, Stark, Dijkhuizen (CR4) 2013; 162B Jamain, Quach, Betancur, Rastam, Colineaux, Gillberg (CR32) 2003; 34 Kumar, Thakur (CR48) 2014; 9 Song, Ichtchenko, Sudhof, Brose (CR27) 1999; 96 Puschel, Betz (CR38) 1995; 15 Marshall, Noor, Vincent, Lionel, Feuk, Skaug (CR2) 2008; 82 Ikeda, Aleksic, Kirov, Kinoshita, Yamanouchi, Kitajima (CR9) 2010; 67 Missler, Sudhof (CR23) 1998; 14 Graf, Kang, Hauner, Craig (CR46) 2006; 26 Law, Lipska, Weickert, Hyde, Straub, Hashimoto (CR33) 2006; 103 Rujescu, Ingason, Cichon, Pietilainen, Barnes, Toulopoulou (CR12) 2009; 18 Zhang, Atasoy, Arac, Yang, Fucillo, Robison (CR30) 2010; 66 Nussbaum, Xu, Payne, Ma, Huang, Gelernter (CR20) 2008; 17 Purcell, Wray, Stone, Visscher, O'Donovan (CR50) 2009; 460 Graf, Zhang, Jin, Linhoff, Craig (CR26) 2004; 119 (CR10) 2008; 455 Jenkins, Apud, Zhang, Decot, Weinberger, Law (CR18) 2014; 39 CR21 Tucker, Zahir, Griffith, Delaney, Chai, Tsang (CR7) 2014; 22 Glessner, Wang, Cai, Korvatska, Kim, Wood (CR3) 2009; 459 Walsh, McClellan, McCarthy, Addington, Pierce, Cooper (CR14) 2008; 320 Szatmari, Paterson, Zwaigenbaum, Roberts, Brian (CR1) 2007; 39 Rozic-Kotliroff, Zisapel (CR41) 2007; 352 M Ikeda (BFmp2015107_CR9) 2010; 67 A Gregor (BFmp2015107_CR6) 2011; 12 T Walsh (BFmp2015107_CR14) 2008; 320 G Kirov (BFmp2015107_CR8) 2008; 17 JY Song (BFmp2015107_CR27) 1999; 96 T Iijima (BFmp2015107_CR42) 2011; 147 JT Glessner (BFmp2015107_CR3) 2009; 459 AJ Law (BFmp2015107_CR33) 2006; 103 MS Ching (BFmp2015107_CR5) 2010; 153B G Rozic (BFmp2015107_CR43) 2011; 6 RP Souza (BFmp2015107_CR16) 2010; 25 CR Marshall (BFmp2015107_CR2) 2008; 82 F Varoqueaux (BFmp2015107_CR28) 2004; 83 A Jenkins (BFmp2015107_CR18) 2014; 39 L Rowen (BFmp2015107_CR22) 2002; 79 M Missler (BFmp2015107_CR23) 1998; 14 AW Puschel (BFmp2015107_CR38) 1995; 15 KE Tansey (BFmp2015107_CR19) 2014; 14 TC Sudhof (BFmp2015107_CR25) 2008; 455 PR Huttenlocher (BFmp2015107_CR37) 1979; 163 Y Kang (BFmp2015107_CR44) 2008; 283 International Schizophrenia C (BFmp2015107_CR10) 2008; 455 SM Brown (BFmp2015107_CR40) 2011; 16 J Nussbaum (BFmp2015107_CR20) 2008; 17 TA Lett (BFmp2015107_CR17) 2011; 132 BFmp2015107_CR21 G Todarello (BFmp2015107_CR15) 2014; 155 S Jamain (BFmp2015107_CR32) 2003; 34 SM Purcell (BFmp2015107_CR50) 2009; 460 T Vrijenhoek (BFmp2015107_CR13) 2008; 83 SL Andersen (BFmp2015107_CR35) 2003; 27 C Sun (BFmp2015107_CR31) 2011; 20 A Noor (BFmp2015107_CR49) 2014; 165B WT Kao (BFmp2015107_CR34) 2010; 107 F Bena (BFmp2015107_CR4) 2013; 162B LE Paraoanu (BFmp2015107_CR39) 2006; 395 D Rujescu (BFmp2015107_CR12) 2009; 18 AC Need (BFmp2015107_CR11) 2009; 17 TJ Siddiqui (BFmp2015107_CR47) 2010; 30 P Szatmari (BFmp2015107_CR1) 2007; 39 T Tucker (BFmp2015107_CR7) 2014; 22 D Kumar (BFmp2015107_CR48) 2014; 9 B Chih (BFmp2015107_CR45) 2006; 51 C Zhang (BFmp2015107_CR30) 2010; 66 ER Graf (BFmp2015107_CR46) 2006; 26 ER Graf (BFmp2015107_CR26) 2004; 119 GZ Tau (BFmp2015107_CR36) 2010; 35 K Tabuchi (BFmp2015107_CR24) 2002; 79 AA Boucard (BFmp2015107_CR29) 2005; 48 G Rozic-Kotliroff (BFmp2015107_CR41) 2007; 352 |
| References_xml | – volume: 15 start-page: 2849 year: 1995 end-page: 2856 ident: CR38 article-title: Neurexins are differentially expressed in the embryonic nervous system of mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.15-04-02849.1995 – volume: 155 start-page: 1 year: 2014 end-page: 7 ident: CR15 article-title: Incomplete penetrance of NRXN1 deletions in families with schizophrenia publication-title: Schizophr Res doi: 10.1016/j.schres.2014.02.023 – volume: 20 start-page: 3042 year: 2011 end-page: 3051 ident: CR31 article-title: Identification and functional characterization of rare mutations of the neuroligin-2 gene (NLGN2) associated with schizophrenia publication-title: Hum Mol Genet doi: 10.1093/hmg/ddr208 – volume: 82 start-page: 477 year: 2008 end-page: 488 ident: CR2 article-title: Structural variation of chromosomes in autism spectrum disorder publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2007.12.009 – volume: 14 start-page: 20 year: 1998 end-page: 26 ident: CR23 article-title: Neurexins: three genes and 1001 products publication-title: Trends Genet doi: 10.1016/S0168-9525(97)01324-3 – volume: 119 start-page: 1013 year: 2004 end-page: 1026 ident: CR26 article-title: Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins publication-title: Cell doi: 10.1016/j.cell.2004.11.035 – volume: 39 start-page: 2170 year: 2014 end-page: 2178 ident: CR18 article-title: Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.65 – volume: 162B start-page: 388 year: 2013 end-page: 403 ident: CR4 article-title: Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature publication-title: Am J Med Genet doi: 10.1002/ajmg.b.32148 – volume: 96 start-page: 1100 year: 1999 end-page: 1105 ident: CR27 article-title: Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.3.1100 – volume: 460 start-page: 748 year: 2009 end-page: 752 ident: CR50 article-title: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder publication-title: Nature doi: 10.1038/nature08185 – volume: 153B start-page: 937 year: 2010 end-page: 947 ident: CR5 article-title: Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders publication-title: Am J Med Genet doi: 10.1002/ajmg.b.31063 – volume: 18 start-page: 988 year: 2009 end-page: 996 ident: CR12 article-title: Disruption of the neurexin 1 gene is associated with schizophrenia publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn351 – volume: 320 start-page: 539 year: 2008 end-page: 543 ident: CR14 article-title: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia publication-title: Science doi: 10.1126/science.1155174 – volume: 39 start-page: 319 year: 2007 end-page: 328 ident: CR1 article-title: Mapping autism risk loci using genetic linkage and chromosomal rearrangements publication-title: Nat Genet doi: 10.1038/ng1985 – volume: 455 start-page: 237 year: 2008 end-page: 241 ident: CR10 article-title: Rare chromosomal deletions and duplications increase risk of schizophrenia publication-title: Nature doi: 10.1038/nature07239 – volume: 17 start-page: 1569 year: 2008 end-page: 1577 ident: CR20 article-title: Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn044 – ident: CR21 – volume: 51 start-page: 171 year: 2006 end-page: 178 ident: CR45 article-title: Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex publication-title: Neuron doi: 10.1016/j.neuron.2006.06.005 – volume: 12 start-page: 106 year: 2011 ident: CR6 article-title: Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 publication-title: BMC Med Genet doi: 10.1186/1471-2350-12-106 – volume: 27 start-page: 3 year: 2003 end-page: 18 ident: CR35 article-title: Trajectories of brain development: point of vulnerability or window of opportunity? publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(03)00005-8 – volume: 165B start-page: 303 year: 2014 end-page: 313 ident: CR49 article-title: Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes publication-title: Am J Med Genet doi: 10.1002/ajmg.b.32232 – volume: 455 start-page: 903 year: 2008 end-page: 911 ident: CR25 article-title: Neuroligins and neurexins link synaptic function to cognitive disease publication-title: Nature doi: 10.1038/nature07456 – volume: 83 start-page: 504 year: 2008 end-page: 510 ident: CR13 article-title: Recurrent CNVs disrupt three candidate genes in schizophrenia patients publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2008.09.011 – volume: 17 start-page: 458 year: 2008 end-page: 465 ident: CR8 article-title: Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia publication-title: Hum Mol Genet doi: 10.1093/hmg/ddm323 – volume: 17 start-page: 946 year: 2009 end-page: 957 ident: CR11 article-title: Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis publication-title: Eur J Hum Genet doi: 10.1038/ejhg.2008.264 – volume: 30 start-page: 7495 year: 2010 end-page: 7506 ident: CR47 article-title: LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0470-10.2010 – volume: 25 start-page: 582 year: 2010 end-page: 585 ident: CR16 article-title: Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response publication-title: Hum Psychopharmacol doi: 10.1002/hup.1146 – volume: 14 start-page: 395 year: 2014 end-page: 399 ident: CR19 article-title: Copy number variants and therapeutic response to antidepressant medication in major depressive disorder publication-title: Pharmacogenomics J doi: 10.1038/tpj.2013.51 – volume: 6 start-page: e18579 year: 2011 ident: CR43 article-title: Dynamic changes in neurexins' alternative splicing: role of Rho-associated protein kinases and relevance to memory formation publication-title: PloS One doi: 10.1371/journal.pone.0018579 – volume: 283 start-page: 2323 year: 2008 end-page: 2334 ident: CR44 article-title: Induction of GABAergic postsynaptic differentiation by alpha-neurexins publication-title: J Biol Chem doi: 10.1074/jbc.M703957200 – volume: 79 start-page: 587 year: 2002 end-page: 597 ident: CR22 article-title: Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity publication-title: Genomics doi: 10.1006/geno.2002.6734 – volume: 67 start-page: 283 year: 2010 end-page: 286 ident: CR9 article-title: Copy number variation in schizophrenia in the Japanese population publication-title: Biol Pyschiatry doi: 10.1016/j.biopsych.2009.08.034 – volume: 147 start-page: 1601 year: 2011 end-page: 1614 ident: CR42 article-title: SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1 publication-title: Cell doi: 10.1016/j.cell.2011.11.028 – volume: 395 start-page: 114 year: 2006 end-page: 117 ident: CR39 article-title: Expression patterns of neurexin-1 and neuroligins in brain and retina of the chick embryo: Neuroligin-3 is absent in retina publication-title: Neurosci Lett doi: 10.1016/j.neulet.2005.10.076 – volume: 79 start-page: 849 year: 2002 end-page: 859 ident: CR24 article-title: Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing publication-title: Genomics doi: 10.1006/geno.2002.6780 – volume: 26 start-page: 4256 year: 2006 end-page: 4265 ident: CR46 article-title: Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1253-05.2006 – volume: 35 start-page: 147 year: 2010 end-page: 168 ident: CR36 article-title: Normal development of brain circuits publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.115 – volume: 34 start-page: 27 year: 2003 end-page: 29 ident: CR32 article-title: Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism publication-title: Nat Genet doi: 10.1038/ng1136 – volume: 459 start-page: 569 year: 2009 end-page: 573 ident: CR3 article-title: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes publication-title: Nature doi: 10.1038/nature07953 – volume: 22 start-page: 792 year: 2014 end-page: 800 ident: CR7 article-title: Single exon-resolution targeted chromosomal microarray analysis of known and candidate intellectual disability genes publication-title: Eur J Hum Genet doi: 10.1038/ejhg.2013.248 – volume: 66 start-page: 403 year: 2010 end-page: 416 ident: CR30 article-title: Neurexins physically and functionally interact with GABA(A) receptors publication-title: Neuron doi: 10.1016/j.neuron.2010.04.008 – volume: 132 start-page: 121 year: 2011 end-page: 124 ident: CR17 article-title: The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response publication-title: Schizophr Res doi: 10.1016/j.schres.2011.08.007 – volume: 9 start-page: e110482 year: 2014 ident: CR48 article-title: Perinatal exposure to bisphenol-A impairs spatial memory through upregulation of neurexin1 and neuroligin3 expression in male mouse brain publication-title: PloS One doi: 10.1371/journal.pone.0110482 – volume: 48 start-page: 229 year: 2005 end-page: 236 ident: CR29 article-title: A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins publication-title: Neuron doi: 10.1016/j.neuron.2005.08.026 – volume: 16 start-page: 585 year: 2011 end-page: 587 ident: CR40 article-title: Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia publication-title: Mol Psychiatry doi: 10.1038/mp.2010.134 – volume: 83 start-page: 449 year: 2004 end-page: 456 ident: CR28 article-title: Neuroligin 2 is exclusively localized to inhibitory synapses publication-title: Eur J Cell Biol doi: 10.1078/0171-9335-00410 – volume: 107 start-page: 15619 year: 2010 end-page: 15624 ident: CR34 article-title: Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1005410107 – volume: 352 start-page: 226 year: 2007 end-page: 230 ident: CR41 article-title: Ca2+ -dependent splicing of neurexin IIalpha publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2006.11.008 – volume: 103 start-page: 6747 year: 2006 end-page: 6752 ident: CR33 article-title: Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0602002103 – volume: 163 start-page: 195 year: 1979 end-page: 205 ident: CR37 article-title: Synaptic density in human frontal cortex - developmental changes and effects of aging publication-title: Brain Res doi: 10.1016/0006-8993(79)90349-4 – volume: 283 start-page: 2323 year: 2008 ident: BFmp2015107_CR44 publication-title: J Biol Chem doi: 10.1074/jbc.M703957200 – volume: 119 start-page: 1013 year: 2004 ident: BFmp2015107_CR26 publication-title: Cell doi: 10.1016/j.cell.2004.11.035 – volume: 96 start-page: 1100 year: 1999 ident: BFmp2015107_CR27 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.3.1100 – volume: 66 start-page: 403 year: 2010 ident: BFmp2015107_CR30 publication-title: Neuron doi: 10.1016/j.neuron.2010.04.008 – volume: 320 start-page: 539 year: 2008 ident: BFmp2015107_CR14 publication-title: Science doi: 10.1126/science.1155174 – volume: 20 start-page: 3042 year: 2011 ident: BFmp2015107_CR31 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddr208 – volume: 39 start-page: 319 year: 2007 ident: BFmp2015107_CR1 publication-title: Nat Genet doi: 10.1038/ng1985 – volume: 83 start-page: 449 year: 2004 ident: BFmp2015107_CR28 publication-title: Eur J Cell Biol doi: 10.1078/0171-9335-00410 – volume: 79 start-page: 849 year: 2002 ident: BFmp2015107_CR24 publication-title: Genomics doi: 10.1006/geno.2002.6780 – volume: 34 start-page: 27 year: 2003 ident: BFmp2015107_CR32 publication-title: Nat Genet doi: 10.1038/ng1136 – volume: 352 start-page: 226 year: 2007 ident: BFmp2015107_CR41 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2006.11.008 – volume: 147 start-page: 1601 year: 2011 ident: BFmp2015107_CR42 publication-title: Cell doi: 10.1016/j.cell.2011.11.028 – volume: 18 start-page: 988 year: 2009 ident: BFmp2015107_CR12 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn351 – volume: 16 start-page: 585 year: 2011 ident: BFmp2015107_CR40 publication-title: Mol Psychiatry doi: 10.1038/mp.2010.134 – volume: 51 start-page: 171 year: 2006 ident: BFmp2015107_CR45 publication-title: Neuron doi: 10.1016/j.neuron.2006.06.005 – volume: 83 start-page: 504 year: 2008 ident: BFmp2015107_CR13 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2008.09.011 – volume: 455 start-page: 903 year: 2008 ident: BFmp2015107_CR25 publication-title: Nature doi: 10.1038/nature07456 – volume: 22 start-page: 792 year: 2014 ident: BFmp2015107_CR7 publication-title: Eur J Hum Genet doi: 10.1038/ejhg.2013.248 – volume: 395 start-page: 114 year: 2006 ident: BFmp2015107_CR39 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2005.10.076 – volume: 6 start-page: e18579 year: 2011 ident: BFmp2015107_CR43 publication-title: PloS One doi: 10.1371/journal.pone.0018579 – volume: 27 start-page: 3 year: 2003 ident: BFmp2015107_CR35 publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(03)00005-8 – volume: 30 start-page: 7495 year: 2010 ident: BFmp2015107_CR47 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0470-10.2010 – volume: 163 start-page: 195 year: 1979 ident: BFmp2015107_CR37 publication-title: Brain Res doi: 10.1016/0006-8993(79)90349-4 – volume: 35 start-page: 147 year: 2010 ident: BFmp2015107_CR36 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.115 – volume: 17 start-page: 458 year: 2008 ident: BFmp2015107_CR8 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddm323 – volume: 155 start-page: 1 year: 2014 ident: BFmp2015107_CR15 publication-title: Schizophr Res doi: 10.1016/j.schres.2014.02.023 – volume: 25 start-page: 582 year: 2010 ident: BFmp2015107_CR16 publication-title: Hum Psychopharmacol doi: 10.1002/hup.1146 – volume: 132 start-page: 121 year: 2011 ident: BFmp2015107_CR17 publication-title: Schizophr Res doi: 10.1016/j.schres.2011.08.007 – volume: 459 start-page: 569 year: 2009 ident: BFmp2015107_CR3 publication-title: Nature doi: 10.1038/nature07953 – volume: 9 start-page: e110482 year: 2014 ident: BFmp2015107_CR48 publication-title: PloS One doi: 10.1371/journal.pone.0110482 – volume: 107 start-page: 15619 year: 2010 ident: BFmp2015107_CR34 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1005410107 – volume: 165B start-page: 303 year: 2014 ident: BFmp2015107_CR49 publication-title: Am J Med Genet doi: 10.1002/ajmg.b.32232 – volume: 460 start-page: 748 year: 2009 ident: BFmp2015107_CR50 publication-title: Nature doi: 10.1038/nature08185 – volume: 12 start-page: 106 year: 2011 ident: BFmp2015107_CR6 publication-title: BMC Med Genet doi: 10.1186/1471-2350-12-106 – volume: 14 start-page: 395 year: 2014 ident: BFmp2015107_CR19 publication-title: Pharmacogenomics J doi: 10.1038/tpj.2013.51 – volume: 14 start-page: 20 year: 1998 ident: BFmp2015107_CR23 publication-title: Trends Genet doi: 10.1016/S0168-9525(97)01324-3 – volume: 48 start-page: 229 year: 2005 ident: BFmp2015107_CR29 publication-title: Neuron doi: 10.1016/j.neuron.2005.08.026 – volume: 153B start-page: 937 year: 2010 ident: BFmp2015107_CR5 publication-title: Am J Med Genet doi: 10.1002/ajmg.b.31063 – volume: 26 start-page: 4256 year: 2006 ident: BFmp2015107_CR46 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1253-05.2006 – ident: BFmp2015107_CR21 doi: 10.1038/mp.2014.156 – volume: 103 start-page: 6747 year: 2006 ident: BFmp2015107_CR33 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0602002103 – volume: 39 start-page: 2170 year: 2014 ident: BFmp2015107_CR18 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.65 – volume: 17 start-page: 946 year: 2009 ident: BFmp2015107_CR11 publication-title: Eur J Hum Genet doi: 10.1038/ejhg.2008.264 – volume: 162B start-page: 388 year: 2013 ident: BFmp2015107_CR4 publication-title: Am J Med Genet doi: 10.1002/ajmg.b.32148 – volume: 79 start-page: 587 year: 2002 ident: BFmp2015107_CR22 publication-title: Genomics doi: 10.1006/geno.2002.6734 – volume: 67 start-page: 283 year: 2010 ident: BFmp2015107_CR9 publication-title: Biol Pyschiatry doi: 10.1016/j.biopsych.2009.08.034 – volume: 82 start-page: 477 year: 2008 ident: BFmp2015107_CR2 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2007.12.009 – volume: 455 start-page: 237 year: 2008 ident: BFmp2015107_CR10 publication-title: Nature doi: 10.1038/nature07239 – volume: 15 start-page: 2849 year: 1995 ident: BFmp2015107_CR38 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.15-04-02849.1995 – volume: 17 start-page: 1569 year: 2008 ident: BFmp2015107_CR20 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn044 |
| SSID | ssj0014765 |
| Score | 2.3995993 |
| Snippet | Neurexin 1 (NRXN1), a presynaptic cell adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including... Neurexin 1 (NRXN1), a presynaptic adhesion molecule, is implicated in several neurodevelopmental disorders characterized by synaptic dysfunction including,... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 701 |
| SubjectTerms | 38 38/39 631/208 631/337 631/378 692/699/476/1799 Adolescent Adult Aged Aged, 80 and over Aging Aging - metabolism Autism Behavioral Sciences Biological Psychology Bipolar disorder Bipolar Disorder - metabolism Brain Calcium-Binding Proteins Cell adhesion & migration Cell adhesion molecules Cell Adhesion Molecules, Neuronal - metabolism Child Child, Preschool Developmental biology Female Fetuses Gene expression Gestational age Humans Infant Infant, Newborn Intellectual disabilities Isoforms Life span Male Medical examination Medicine Medicine & Public Health Mental disorders Mental health Middle Aged Neocortex - growth & development Neocortex - metabolism Nerve Tissue Proteins - metabolism Nervous system Neural Cell Adhesion Molecules Neurodevelopmental disorders Neurosciences Observations original-article Pharmacotherapy Polymerase chain reaction Prefrontal cortex Properties Protein Isoforms Proteins Psychiatry Review boards Schizophrenia Schizophrenia - metabolism Young Adult |
| Title | Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging |
| URI | https://link.springer.com/article/10.1038/mp.2015.107 https://www.ncbi.nlm.nih.gov/pubmed/26216298 https://www.proquest.com/docview/1781818188 https://www.proquest.com/docview/2645770870 https://www.proquest.com/docview/1782830331 https://www.proquest.com/docview/1787968570 https://pubmed.ncbi.nlm.nih.gov/PMC4731316 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3raxQxEA_aIvhFfLtaS4SKD1i6eWc_SZWWInhIqXDghyWbzdIDu3d6V6j_vTPZ3LZ7lrKfQmZDHjOZSWbyG0L2rG5bJ4TMC9_qXDZB5I5bnyulmrqUytYW3w5_m-jjH_LrVE3ThdsyhVWu98S4UTdzj3fk-6C4lTEFsNenxe8cs0ahdzWl0LhLthG6DLnaTIcDF5MmppJkQqG308r0Pq8Qdv8csSqZgoIZaaTNffmaYtoMmtzwnEaFdPSQPEiWJD3ol_4RuRO6x-Ren1vy7xPyE2E3wuWso4y-n5xMJ-wDXaKzOtDZco6mKg2XKQq2o_1rRRoz9tEuzOFMGi-5aXMVVERd19CY1OgpOT06PP1ynKdMCrnXsljlPoBZUXjt2sZp3_LCcQWqKVgTWllb71QoasclmFPBtQLshuCFEiDgZVmXQTwjW928Cy8IVbwBKg1Whg1ScWu9FkUZOPzRNKWUGfm4nszKJ5RxTHbxq4rebmGr80WFMw8Fk5G9gXjRg2vcTPYOV6VCkYO2vEsvB6BHCF5VHcSOIFheRnZGlCAqfly9XtcqieqyYgZsFvzsjdVXfJeRN0M1NozRabAgF7EJxFETgt1KY0qN6QQy8rznpGHMXHOmeQkdMCMeGwgQA3xc083OIha4NIIJpjPyds2N10b2_1S-vH2Ir8h9oNR9QOcO2Vr9uQivweha1btRsnbJ9ufDyfeTf_S9Kuo |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB5qRfRFvButOkKLWghN5p4HkaKWrW33QVZY8GFIJhNcsNnV3WL7o_yPnjO5tLuWvpU8hTkZ5nJmzjk5l4-QTaOqKudcxImrVCxKz-OcGRdLKcsiE9IUBnOHj4Zq8E18GcvxGvnb5cJgWGV3J4aLupw6_Ee-A4Jbap0Ae32Y_YoRNQq9qx2ERsMWB_7sD5hs8_f7n2B_txjb-zz6OIhbVIHYKZEsYudBxCZO5VWZK1exJGcSrmlvtK9EYVwufVLkTIBq4fOKgwz1jkuw-kGXKjLPodsb5CbI3QRtPT3u7btU6IBcmXKJzlUj2nTAhJudYyyNmUp40UsCcFUMXJCDqzGaK47aIP_27pG7reJKdxtOu0_WfP2A3GqgLM8eku9Y5cOfTmqa0rfDr-Nh-o7O0Tfu6WQ-Rc2Y-tM26LamTXIkDQCBtPZTMIHDP3Vanscw0bwuacBQekRG17HEj8l6Pa39U0IlK4FKgVJjvJDMGKd4knkGX5RlJkREtrvFtK4tao7YGj9tcK5zY49nFlceXnRENnviWVPL43KyN7grFk849OXyNlEBRoS1suxuGAjW5ovIxhIlnEy33Nztq21vhrlNNahI-JhLm8_ZPCKv-2bsGIPhYENOQhdYto3z9EoanSlEL4jIk4aT-jkzxVLFMhiAXuKxngBLji-31JMfofS40DzlqYrIVseNF2b2_1I-u3qKr8jtwejo0B7uDw-ekzvwlWpiSTfI-uL3iX8B-t6ieBlOGSX2mk_1PyKuZhk |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3ra9RAEB_qFcUv4tto1RVafEC4ZN_5IFJtS2v1KKXCgR9Cstnggc2d3hXbP83_zpk8rr2z9FvJp7CTZR8zO7OZxw9g3eqyzISQYeRKHcrCizDj1oVKqSJPpLK5pdzhrwO9-01-HqrhCvztcmEorLI7E-uDuhg7-kfeR8WtjImQvfplGxZxsLXzYfIrJAQp8rR2cBoNi-z7sz94fZu-39vCvd7gfGf76NNu2CIMhE7LaBY6j-o2cjori0y7kkcZV3hke2t8KXPrMuWjPOMSzQyflQL1qXdCCWT8JMkTL7DbG7Bq6FLUg9WP24ODw7kLQ5oaxzIWilytVrbJgZGw_WMqlBkrfDEL6nBZKVzQissRm0tu21ob7tyFO60ZyzYbvrsHK766DzcbYMuzB_Cdan7401HFYvZmcDgcxG_ZlDzlno2mY7KTmT9tQ3Ar1qRKshoukFV-jBfi-g87K84jmlhWFaxGVHoIR9exyI-gV40r_wSY4gVSaTRxrJeKW-u0iBLP8YuiSKQM4F23mKlrS5wT0sbPtHa1C5seT1JaeXwxAazPiSdNZY_LyV7TrqQk79iXy9q0BRwRVc5KN-uBUKW-ANYWKFFO3WJzt69pe05M09igwUSPvbT5nOkDeDVvpo4pNA435KTugoq4CRFfSWMSTVgGATxuOGk-Z655rHmCAzALPDYnoALkiy3V6EddiFwaEYtYB7DRceOFmf2_lE-vnuJLuIUSnX7ZG-w_g9v4kW4CS9egN_t94p-j8TfLX7RixiC9ZsH-Bw-wa7Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurexin+1+%28NRXN1%29+splice+isoform+expression+during+human+neocortical+development+and+aging&rft.jtitle=Molecular+psychiatry&rft.au=Jenkins%2C+A+K&rft.au=Paterson%2C+C&rft.au=Wang%2C+Y&rft.au=Hyde%2C+T+M&rft.date=2016-05-01&rft.pub=Nature+Publishing+Group&rft.issn=1359-4184&rft.eissn=1476-5578&rft.volume=21&rft.issue=5&rft.spage=701&rft.epage=706&rft_id=info:doi/10.1038%2Fmp.2015.107&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon |